Brazil appears to have jumped the gun by officially announcing the dispatch of a plane to transport two million doses of the Covid-19 vaccine from India, and New Delhi made it clear on Thursday that decisions on supplies to foreign countries will take longer. A statement issued by Brazil’s Foreign …
Read More »
For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »
A government panel of experts reportedly approved the vaccine, developed by AstraZeneca and the University of Oxford, for emergency use in India to provide immunity against coronavirus disease (Covid-19). According to the Reuters news agency, a committee of experts in the field, created by the Comptroller General of Drugs of …
Read More »
The Serum Institute of India, which is manufacturing and testing the Oxford / AstraZeneca coronavirus vaccine in the country, said Monday. awaited regulatory approval to take in a few days. Serum CEO Adar Poonawalla said the vaccine, called Covishield in India, should be licensed by January. “The emergency use authorization …
Read More »
Coronavirus: Adar Poonawalla Says Serum Institute Will Give First 50 Million Doses Of Covishield To India New Delhi: Stating that the delay in approval of the COVID-19 Oxford-AstraZeneca vaccine, produced en masse by his company, was not concerning, Adar Poonawalla from the Serum Institute of India (SII) said the inoculant …
Read More »
A ‘safe and effective’ coronavirus vaccine will be available to the general public in the country next May or June, said Adar Poonawalla, executive director of the Serum Institute of India at the Hindustan Times Leadership Summit 2020. The Pune-based drug maker has signed an agreement with British-Swedish company AstraZeneca …
Read More »
After pharmaceutical company AstraZeneca announced the resumption of its Covid-19 vaccine trial in the UK, its partner at India Serum Institute said it will also restart trials once the General Medicines Controller of India (DGCI) gives its okay. The DGCI previously sent a show of cause notice to the Pune-based …
Read More »